Amgen to request 340B visit claims data starting November 15
Issue
340B drug pricingIn court
Next: · Amgen to request 340B visit claims data starting November 15
Beginning November 15, 2026, Amgen will ask for standard healthcare visit and service claims data tied to all 340B pharmacy and medical dispenses of its medicines. Since June 1, 2026 it has asked for claims-level data on those dispenses.
No health center is named.
Sources for this story
Amgen Inc. — 340B Program Integrity Policy Update (company statement)Part of
- 340B drug pricing
Manufacturer restrictions and data demands
Sources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
More in Risk & Compliance
Nov 9
CMS gives drugmakers no safe harbor when 340B entities withhold claim data
Nov 5
Missouri drops and Colorado delays the Medicaid work requirement hardship exception
Nov 4
CMS makes Part D 340B claims reporting mandatory starting in 2027
Nov 3
HHS finalizes Section 504 rule on gender dysphoria and disability
FQHC Talent. (2026, May 15). Amgen to request 340B visit claims data starting November 15. Source: Amgen Inc. — 340B Program Integrity Policy Update (company statement). Retrieved November 11, 2026, from https://www.fqhctalent.com/intel/amgen-340b-visit-claims-data-request-november-15-2026